Publications

February 2001
Teaching Note

CVS: The Web Strategy TN

By: John A. Deighton

Teaching Note for (9-500-008). View Details

Keywords: Pharmaceutical Industry; Pharmaceutical Industry

January 2001
Case

Merck Global Health Initiatives (A)

By: James E. Austin, Diana Barrett and James Weber

The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details

Keywords: Programs; Philanthropy and Charitable Giving; Health Disorders; Health Care and Treatment; Private Sector; Public Sector; Alliances; Problems and Challenges; Pharmaceutical Industry; Botswana

January 2001 (Revised May 2003)
Case

Novartis Pharma: The Business Unit Model

By: Srikant M. Datar, Carin-Isabel Knoop and Cate Reavis

In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing).... View Details

Keywords: Restructuring; Recruitment; Product Marketing; Organizational Structure; Problems and Challenges; Health Industry; Health Industry

January 2001
Case

Abgenix and the XenoMouse

By: Robert J. Dolan

Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to... View Details

Keywords: Product Development; Marketing Strategy; Health Testing and Trials; Risk and Uncertainty; Technological Innovation; Innovation Strategy; Science-Based Business; Biotechnology Industry

January 2001 (Revised July 2003)
Case

Pharmacyclics: Financing Research & Development

By: Malcolm P. Baker, Richard S. Ruback and Aldo Sesia

Pharmacyclics (NASDAQ: PCYC), a pharmaceutical company that manufactures products that will improve existing therapeutic treatments for cancer, arteriosclerosis, and retinal disease, was considering a $60 million private placement in February 2000. The company had more... View Details

Keywords: Valuation; Cash Flow; Financing and Loans; Business Startups; Financial Strategy; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry

2001
Chapter

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

By: Rebecca Henderson and Ian Cockburn

U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details

Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry

Find at Harvard

Read Now

December 2000 (Revised January 2001)
Background Note

Promise of Functional Foods, The

By: Ray A. Goldberg, Carin-Isabel Knoop and Laure Mougeot Stroock

This case presents a definition of functional foods or nutraceuticals (food or food ingredients that could provide a health benefit beyond the traditional nutrients they contain), a description of some of the major obstacles to their commercialization and... View Details

Keywords: Food; Private Sector; Public Sector; Health; Product Development; Production; Commercialization; Food and Beverage Industry; Food and Beverage Industry

Find at Harvard

October 2000 (Revised March 2003)
Case

Merck & Company: Evaluating a Drug Licensing Opportunity

By: Richard S. Ruback and David B Krieger

This explores the valuation of an opportunity to license a compound before it enters clinical trials. Describes Merck's decision tree evaluation process is presented. Information required to evaluate a specific licensing opportunity is provided, including the costs of... View Details

Keywords: Decision Making; Cost vs Benefits; Opportunities; Valuation; Outcome or Result; Pharmaceutical Industry

2000
Chapter

Millennium Pharmaceuticals, Inc.

By: S. Thomke and A. Nimgade

Keywords: Pharmaceutical Industry

October 2000
Case

Procter & Gamble Italy: The Pringles Launch (A)

By: Roy D. Shapiro

Procter & Gamble's (P&G) Pringles potato chips have been a very successful brand. This case reviews the development and first launch in the United States, then in markets around the world. Italy is one of the last countries where Pringles will be launched. Should P&G... View Details

Keywords: Globalized Markets and Industries; Brands and Branding; Marketing Strategy; Product Launch; Emerging Markets; Product Development; Adoption; Value Creation; Pharmaceutical Industry; United States

October 2000
Teaching Note

Kendle International Inc. TN

By: Dwight B. Crane and Indra Reinbergs

Teaching Note for (9-200-033). View Details

Keywords: Biotechnology Industry; Biotechnology Industry

October 2000
Supplement

Hans Fritz at Novartis Thailand (C)

By: Carin-Isabel Knoop and Michael Y. Yoshino

Supplements the (A) case. View Details

Keywords: Pharmaceutical Industry; Thailand

October 2000
Supplement

Hans Fritz at Novartis Thailand (D): The First 18 Months

By: Michael Y. Yoshino and Carin-Isabel Knoop

Supplements the (A) case. View Details

Keywords: Pharmaceutical Industry; Thailand